Navigation Links
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Date:6/1/2009

"As the leading cause of cancer deaths worldwide, lung cancer is a complex disease that requires new therapeutic options for patients," said Laura Brege, executive vice president and chief operating officer at Onyx Pharmaceuticals. "We are committed to studying Nexavar to understand how it may play a role in the treatment paradigm of this difficult-to-treat disease."

About Non-Small Cell Lung Cancer (NSCLC)

NSCLC accounts for 85-90 percent of diagnosed lung cancers(1) and is a disease in which malignant (cancer) cells form in the tissues of the lung. It is characterized by several types of lung cancers, each of which grow and spread in different ways, including: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.(1)

Every year 1.4 million people worldwide will be diagnosed with lung cancer and 1.2 million will die from the disease.(2) Nearly 60 percent of Americans diagnosed with lung cancer die within one year of their diagnosis and 75 percent die within 2 years. These survival rates have not improved in the past 10 years.(3)

Nexavar's Differentiated Mechanism

Nexavar, an oral anti-cancer therapy, is currently approved in more than 70 countries for liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including, brea
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 The Hearing Aid ... five years to 2014. Following a multiyear drop during ... demographic trends, the expansion of private healthcare coverage and, ... that Hearing Aid Clinics industry revenue will ... billion during the five years to 2014. , According ...
(Date:7/30/2014)... in every twenty elderly American adults is being financially ... burgeoning public health crisis especially affects poor and black ... researchers, and any citizen who cares about the dignity ... of Weill Cornell Medical College in the US. She ... elder abuse, the findings of which appear in the ...
(Date:7/30/2014)... tests could be created to diagnose diseases such as ... to earlier intervention, according to new findings from the ... the components of memory using a combination of tests ... to create a diagnostic tool for distinguishing between different ... of amnesia caused by head trauma. , Dr ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The global ... billion by 2020, according to a new study by ... procedures and the growing prevalence of diabetes, obesity and ... the forecast period. In addition, the introduction of technologically ... penetration of minimally invasive procedures in emerging Asian markets ...
(Date:7/30/2014)... TX (PRWEB) July 30, 2014 ... Louisiana Attorney General’s Office against the maker of ... alleges that Fresenius Medical Care defrauded the state, ... these products, called dialysates, before they were recalled ... complaints related to these products pending in the ...
Breaking Medicine News(10 mins):Health News:Hearing Aid Clinics in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Hearing Aid Clinics in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Older adults are at risk of financial abuse 2Health News:Hope for more accurate diagnosis of memory problems 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 3Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 2Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 3
... post-traumatic stress disorder show reduced pain sensitivity, a pattern ... the brain, according to a report. ,Post-traumatic stress ... in individuals exposed to a traumatic event. It is ... avoidance of stimuli related to the event, according to ...
... pharma major Ranbaxy Laboratories Limited has received the approval ... manufacture and market generic hypertension drug Atenolol in the ... of 25 mg, 50 mg, and 100 mg dosage ... the first quarter of 2007, the company said in ...
... woman has brought about a revolution in the lives of ... retiree from Hong Kong, decided one day to live in ... That momentous decision has made a huge difference to hundreds ... the only nurse at the Tanshan Leper Rehabilitation Village in ...
... from over in Bihar, which recorded 51 new cases in 2006.// ... in the state even though millions were spent on a series ... put the figure of polio cases at over 60. ... detected in Kishanganj, Purnea, East Champaran and Sitamarhi districts. ...
... in the Archives of Pediatrics & Adolescent Medicine, one of ... vitamin// and mineral supplement while pregnant may be less likely ... have babies weighing less than 2,500 grams, and their newborns ... seven days of life. ,Low birth weight, or ...
... widely held belief that cutting down on calories could ... acquired added meaning.// Researchers from University of Alabama at ... risk of cancer is the body composition (being lean ... instead of consumed, which mounts the risk of cancer., ...
Cached Medicine News:Health News:Patients With PTSD Experience Less Pain Sensitivity 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 2Health News:A ‘Good Samaritan’ to the Aid of Lepe 3Health News:Multivitamins Can Reduce Risk Of Low Birth Weight 2
(Date:7/29/2014)... , July 29, 2014  Alexza Pharmaceuticals, Inc. ... is participating in two healthcare conferences during the third ... the Morgan Stanley Global Healthcare 2014 Conference.  Alexza,s corporate ... Conference.  The details on each event are below: ... August 11, 2014 in Boston , ...
(Date:7/29/2014)... 2014 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today reported net income for the quarter ... diluted share, and non-GAAP net income of $94.0 million, or ... a year earlier was $93.3 million, or $0.81 per diluted ... per diluted share.  Net sales for the ...
(Date:7/29/2014)... , July 29, 2014 New high priced ... Part D by a projected $2.9 to $5.8 billion ... actuarial firm Milliman released today by the Pharmaceutical Care ... premiums could increase by as much as 8.6 percent ... drugs, including Sovaldi and Olysio. The study ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2
... 2012  BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... present a company update at the J.P. Morgan Healthcare Conference ... a.m. PT.  Interested parties may access a ... section of the BioMarin website, www.BMRN.com .  A replay ...
... UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") ... Balance Sheet over the last twelve months, as referenced ... the Year ended September 30, 2011. In the report ... notes and accounts payable, decreased to $284,636, a 59% ...
Cached Medicine Technology:BioMarin to Present at the J.P. Morgan Healthcare Conference 2UV Flu Technologies Aggressively Paying Down Debt to Build Platform for Expected Growth in Consumer and Hospital Markets 2UV Flu Technologies Aggressively Paying Down Debt to Build Platform for Expected Growth in Consumer and Hospital Markets 3
... is a primary component of an integrated ... sampling, and slide preparation all strictly ... LBP Processor produces high-quality sample slides featuring ... of cytology specimen types. It processes 40 ...
... offer a safe alternative to using positive ... applications such as PCR(a), pipetting radioactive materials ... are excellent for tissue culture, gel loading, ... prevent aerosol contaminants and liquids from reaching ...
... Packed conveniently in plastic-wrapped racks of ... to useno need to autoclave. Sterilized Diamond ... efficient sterilization and are delivered with a ... irradiation. Sterilized Diamond Tips are certified free ...
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
Medicine Products: